BioArctic Interim Report for the period October – December 2025
STOCKHOLM, Feb. 18, 2026 /PRNewswire/ — A transformative year with record financial results Events during the fourth quarter 2025 Leqembi® Iqlik™ was launched for weekly maintenance dosing and Eisai completed rolling sBLA submission for …